Related Experiment Video

Updated: May 13, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Immunomodulatory properties of farnesoids: the new steroids?

A Mor1, E Aizman, J Chapman

  • 1Department of Medicine, New York University School of Medicine, 450 E 29th Street, New York, NY 10016, USA. Adam.Mor@NYUMC.org

Current Medicinal Chemistry
|February 26, 2013
PubMed

Insights

Farnesylthiosalisylic acid (FTS) effectively treats cancer by targeting Ras proteins. FTS also demonstrates significant anti-inflammatory effects, showing promise for autoimmune and inflammatory diseases.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Ras proteins are crucial in cancer but also activate the immune system.
  • Farnesylthiosalisylic acid (FTS) is a known anticancer agent targeting Ras.
  • The role of Ras in inflammation suggests FTS may have therapeutic potential beyond cancer.

Purpose of the Study:

  • To review the anti-inflammatory properties of FTS.
  • To explore the potential of FTS in treating autoimmune and inflammatory conditions.
  • To summarize research on FTS's mechanisms and efficacy in disease models.

Main Methods:

  • Extensive study of FTS in multiple animal models of autoimmune and inflammatory diseases.
  • Investigation of molecular mechanisms, signaling pathways, and inflammatory mediators.
  • Review of published data on FTS's effects.

Main Results:

  • FTS exhibits potent anti-inflammatory properties in various autoimmune disease models.
  • FTS showed potential in models of type I and type II diabetes.
  • FTS was effective in models of contact dermatitis, allergic inflammation, and nephritis.

Conclusions:

  • FTS demonstrates significant anti-inflammatory effects across multiple disease models.
  • FTS has potential as a safe and effective anti-inflammatory drug.
  • Further research supports FTS for treating inflammatory and autoimmune conditions.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...